Premedication with simethicone and N-acetylcysteine for improving mucosal visibility during upper gastrointestinal endoscopy in a Western population

 

 Permissions and Reprints

Abstract

Background and study aim Pre-endoscopic use of a preparation with tensioactive and mucolytic agents improved gastric mucosa visualization in Eastern studies. Data on Western population are scanty.

Patients and methods This prospective, endoscopist-blinded, randomized study enrolled patients who underwent esophagogastroduodenoscopy in a single center. Before endoscopy patients, were randomized to receive or not receive an oral preparation with simethicone and N-acetylcysteine in water. A pretested score (Crema Stomach Cleaning Score [CSCS]) for gastric mucosa cleaning evaluation was used. In detail, the stomach was divided into the antrum, body, and fundus and a score of 1 to 3 was assigned to each part (the higher the score, the better the preparation), and a total value ≤ 5 was considered as insufficient. Time between endoscope insertion and clean achievement (mouth to clean time) or the end of examination (mouth to mouth time) was recorded.

Results A total of 197 patients were enrolled. The mean overall CSCS value and mucosal cleaning in all parts was better in treated patients than in controls. Prevalence total score ≤ 5 was significantly lower in patients treated before endoscopy. Need for water flush occurred less frequently in treated patients (P < 0.0001). The mouth to clean time was lower in the treated than in the control group (2.3 ± 1.6 vs 3.8 ± 1.6 min; P < 0.001), whereas no significant difference in mouth to mouth time emerged.

Conclusions Data from this study show that premedication with simethicone and N-acetylcysteine results in significantly better endoscopic visualization of gastric mucosa, and the proposed CSCS could be useful for standardizing this evaluation.

Publication History

Received: 06 August 2020

Accepted: 05 October 2020

Article published online:
25 January 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Bray F, Ferlay J, Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2018; 68: 394-424
  CrossrefPubMedGoogle Scholar
• 2 Arnold M, Park JY, Camargo MC. et al. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035.. Gut 2020; 69: 823-829
  CrossrefPubMedGoogle Scholar
• 3 Pimentel-Nunes P, Libânio D, Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51: 365-388
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Lai EJ, Calderwood AH, Doros G. et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc 2009; 69: 620-625
  CrossrefPubMedGoogle Scholar
• 5 Beg S, Ragunath K, Wyman A. et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut 2017; 66: 1886-1899
  CrossrefPubMedGoogle Scholar
• 6 Chang WK, Yeh MK, Hsu HC. et al. Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy: premedication before upper endoscopy. J Gastroenterol Hepatol 2014; 29: 769-774
  CrossrefPubMedGoogle Scholar
• 7 Chang C-C, Chen S-H, Lin C-P. et al. Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: an endoscopist-blinded, prospective, randomized study. World J Gastroenterol 2007; 13: 444-447
  CrossrefPubMedGoogle Scholar
• 8 Sajid MS, Rehman S, Chedgy F. et al. Improving the mucosal visualization at gastroscopy: a systematic review and meta-analysis of randomized, controlled trials reporting the role of Simethicone ± N-acetylcysteine. Transl Gastroenterol Hepatol 2018; 3: 29
  CrossrefPubMedGoogle Scholar
• 9 Elvas L, Areia M, Brito D. et al. Premedication with simethicone and N-acetylcysteine in improving visibility during upper endoscopy: a double-blind randomized trial. Endoscopy 2016; 49: 139-145
  Article in Thieme ConnectPubMedGoogle Scholar
• 10 Basford PJ, Brown J, Gadeke L. et al. A randomized controlled trial of pre-procedure simethicone and N-acetylcysteine to improve mucosal visibility during gastroscopy – NICEVIS. Endosc Int Open 2016; 4: E1197-E202
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174
  Google Scholar
• 12 Monrroy H, Vargas JI, Glasinovic E. et al. Use of N-acetylcysteine plus simethicone to improve mucosal visibility during upper GI endoscopy: a double-blind, randomized controlled trial. Gastrointest End 2018; 87: 986-993
  CrossrefPubMedGoogle Scholar
• 13 Zullo A, Manta R, De Francesco V. et al. Diagnostic yield of upper endoscopy according to appropriateness: a systematic review. Dig Liver Dis 2019; 51: 335-339
  CrossrefPubMedGoogle Scholar
• 14 Menon S, Trudgill N. How commonly is upper gastrointestinal cancer missed at endoscopy? Meta-analysis. . End Int Open 2014; 2: E46-E50
  Article in Thieme ConnectPubMedGoogle Scholar
• 15 Yakamarthi S, Witherpoon P, McCole D. et al. Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy 2005; 36: 874-879
  Article in Thieme ConnectPubMedGoogle Scholar
• 16 Marrelli D, Pedrazzani C, Morgagni P. et al. Changing clinical and pathological features of gastric cancer over time. Br J Surg 2011; 98: 1273-1283
  CrossrefPubMedGoogle Scholar
• 17 Cha JM, Won KY. et al. Effect of pronase premedication on narrow-band imaging endoscopy in patients with precancerous conditions of stomach. Dig Dis Sci 2014; 59: 2735-2741
  CrossrefPubMedGoogle Scholar
• 18 Li Y, Du F, Fu D. The effect of using simethicone with or without N-acetylcysteine before gastroscopy: a meta-analysis and systemic review. Saudi J Gastroenterol 2019; 25: 218-222
  CrossrefPubMedGoogle Scholar
• 19 Park JM, Huo SM. et al. Longer observation time increases proportion of neoplasms detected by esophagogastroduodenoscopy. Gastroenterology 2017; 153: 460-469
  CrossrefPubMedGoogle Scholar
• 20 Asl SMKH. Efficacy of premedication with activated Dimethicone or N-acetylcysteine in improving visibility during upper endoscopy. World J Gastroenterolog 2011; 17: 4213
  CrossrefPubMedGoogle Scholar
• 21 Zullo A, Esposito G, Ridola L. et al. Prevalence of lesions detected at upper endoscopy: an Italian survey. Eur J Int Med 2014; 25: 772-776
  CrossrefPubMedGoogle Scholar